Director
DIN: 07915471
Vishwajit Singh is currently associated with 2 companies in various capacities such as Individual Promoter and Designated Partner. They serve as a Director at REMEDAZO GLOBAL MEDICAL SERVICES PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 07915471.Vishwajit Singh has previously been associated with 1 company in roles such as Director.Vishwajit Singh is currently involved in 2 different roles. Their most recent position is with BRINCE CONSULTANCY LLP as a Designated Partner. The first company Vishwajit Singh was appointed to was REMEDAZO GLOBAL MEDICAL SERVICES PRIVATE LIMITED. Vishwajit Singh is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Vishwajit Singh is currently associated with 2 companies in various capacities such as Individual Promoter and Designated Partner. They serve as a Director at REMEDAZO GLOBAL MEDICAL SERVICES PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 07915471.Vishwajit Singh has previously been associated with 1 company in roles such as Director.Vishwajit Singh is currently involved in 2 different roles. Their most recent position is with BRINCE CONSULTANCY LLP as a Designated Partner. The first company Vishwajit Singh was appointed to was REMEDAZO GLOBAL MEDICAL SERVICES PRIVATE LIMITED. Vishwajit Singh is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
2
Male
India
Call +91 81049 46419 and we'll pull the verified contact details for you.
Current Companies (1)
Current LLPs (1)
Past Companies (1)
1y 7m 10 Months Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| REMEDAZO GLOBAL MEDICAL SERVICES PRIVATE LIMITED | Individual Promoter | 09-Oct-2018 |